Home/Investors/Longwood Fund

Longwood Fund

Biotech Investor · 6 portfolio companies

Portfolio

6

Focus Areas

18

Top Stage

Phase 1

Investment Focus

Neuropsychiatry Mental Health Anxiety Disorders Substance Use Disorders Cognitive Impairment Hepatobiliary Cardio-Renal-Metabolic Neurological Rare Diseases Hematology Metabolic Disorders Oncology Autoimmune and Inflammatory Diseases Cardiometabolic Diseases Immunology & Inflammation

Portfolio Companies

Company	Stage	Valuation	Focus
Newleos	Phase 1	—	Neuropsychiatry, Mental Health
Rectify Pharmaceuticals	Pre-clinical	—	Hepatobiliary, Cardio-Renal-Metabolic
Be Biopharma	Phase 1	—	Rare Diseases, Hematology
Photys Therapeutics	Pre-clinical	—	Oncology, Autoimmune and Inflammatory Diseases
Solu Therapeutics	Phase 1	—	Oncology, Immunology & Inflammation
Tome Biosciences	preclinical	—	Genetic Diseases, Oncology

Frequent Co-Investors

Atlas Venture2 shared ARCH Venture Partners2 shared DCVC Bio1 shared Andreessen Horowitz1 shared Bristol Myers Squibb1 shared Nextech Invest1 shared Forbion1 shared RA Capital Management1 shared